Kuehn L, Dahlmann B, Heath R, Kay J
Biochemische Abteilung, Diabetes-Forschungsinstitut, Düsseldorf.
Biol Chem Hoppe Seyler. 1988 May;369 Suppl:299-305.
The skeletal muscle content of three rat proteinase inhibitors, a 1-proteinase inhibitor, contrapsin and a 1-cysteine proteinase inhibitor was measured by immunochemical techniques following streptozotocin-induced diabetes. When compared with normal rats, a 1-cysteine proteinase inhibitor and a 1-proteinase inhibitor levels remained essentially unchanged, whereas the content of rat contrapsin was reduced by nearly 80% after the onset of diabetes. Similarly, fasting of rats for three days resulted in a lowering of the levels of contrapsin in skeletal muscles. Under these conditions, levels of chymotrypsin-like activity (chymase) were increased by 150%, whereas the content of the trypsin-like, neutral proteinase was unchanged. Kinetic studies in vitro with Tosyl-Gly-Pro-Arg-4-nitroanilide as substrate showed no inhibition of the trypsin-like proteinase by a 1-proteinase inhibitor, while contrapsin inhibited the enzyme with a Ki value of 40nM. The changing pattern of these proteinases and their potential inhibitors (chymase/a 1-proteinase inhibitor and trypsin-like proteinase/contrapsin) may be a factor contributing to muscle wasting as observed in diabetes and fasting.
采用免疫化学技术测定链脲佐菌素诱导糖尿病大鼠三种大鼠蛋白酶抑制剂(α1-蛋白酶抑制剂、抗胰蛋白酶和α1-半胱氨酸蛋白酶抑制剂)的骨骼肌含量。与正常大鼠相比,α1-半胱氨酸蛋白酶抑制剂和α1-蛋白酶抑制剂水平基本保持不变,而糖尿病发病后大鼠抗胰蛋白酶含量降低了近80%。同样,大鼠禁食三天导致骨骼肌中抗胰蛋白酶水平降低。在这些条件下,类胰凝乳蛋白酶活性(糜酶)水平增加了150%,而类胰蛋白酶中性蛋白酶的含量未发生变化。以甲苯磺酰-L-甘氨酰-L-脯氨酰-L-精氨酸-4-硝基苯胺为底物进行的体外动力学研究表明,α1-蛋白酶抑制剂对类胰蛋白酶无抑制作用,而抗胰蛋白酶以40nM的Ki值抑制该酶。这些蛋白酶及其潜在抑制剂(糜酶/α1-蛋白酶抑制剂和类胰蛋白酶/抗胰蛋白酶)的变化模式可能是导致糖尿病和禁食时观察到的肌肉萎缩的一个因素。